Obtaining the Campaigns list from the server has failed!
Server response:
CM Ad cahger Server plugin is not active on https://legendarygroup.co/admanager/

Global Artificial Blood Vessels Market (2020 to 2025) – Featuring Humacyte, Jotec GmbH, LeMaitre Vascular Among Others – ResearchAndMarkets.com

DUBLIN–()–The “Artificial Blood Vessels Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client’s requirements.
  • 3 months of analyst support.

The majority of the artificial blood vessels are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-Pacific is witnessing an emergence of some small players due to the rise of awareness.

People are facing problems with blocked blood vessels that can cause some extreme life-threatening conditions. Hence, it is essential to replace a damaged blood vessel either by artificial vascular prostheses or through another arteries or veins from the body. The research institutes have thus developed artificial blood vessels made from special polymers, that has exceptional mechanical properties.

Surgeons initially transplanted veins or arteries from donors to replace the damaged or diseased arteries from the human body. Transplanting vessels from the patient’s own body has various problems such as development of arteriosclerosis and several post-surgery complications. Hence, to avoid such difficulties, artificial blood vessels were created by researchers, thus augmenting the market growth.

However, the presence of a stringent regulatory framework for the approval of artificial vessels will limit the market growth. Moreover, the high cost associated with transplants and surgeries will further impede the market growth.

Key Market Trends

Application in Aortic Disease is Expected to cover a Large Share of the Market

As per a report 2015 report by D. P. J. Howard et al., published in Wiley Online Library, the incidence of acute abdominal aortic aneurysm (AAA) events per 100 000 population per year was 55 in men aged between 65 and 74 years, but increased to 112 at age between 75 and 84 years and to 298 at age 85 years or above. Therefore as the geriatric population is increasing as per 2017 report on “World Aging Population” by the United Nations. Hence, the prevalence of aortic diseases is expected to increase in the future.

When an aneurysm ruptures, surgery is needed. Surgery thus involves removing the section of aorta where the aneurysm is and replacing it with an artificial blood vessel. Therefore with the increasing incidence, artificial blood vessels application is expected to increase and this, in turn, will help the market growth.

North America is Expected to Dominate the Artificial Blood Vessels Market

North America holds the major share of the market due to well-developed healthcare infrastructure, and logy advancements in this region.

Besides, the growing prevalence of aortic diseases in the U.S. is also likely to boost the market growth. As per the Center for Diseases Control and Prevention 2019 report, aortic aneurysms were the cause of 9,928 deaths in 2017 in the United States. The number of smokers, who are more prone to aortic diseases is also increasing in the US. Hence, the growing burden of such diseases will augment the artificial blood vessels market.

However, the United States also have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Aortic Diseases

4.2.2 Growing Adoption of Minimally Invasive Surgeries

4.2.3 Technological Advancements in Development of Artificial Blood Vessels

4.3 Market Restraints

4.3.1 High Cost Associated with Transplants and Surgeries

4.4 Porter’s Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Application

5.1.1 Aortic Disease

5.1.2 Peripheral Artery Disease

5.1.3 Hemodialysis

5.2 By Polymer

5.2.1 Polydioxanone

5.2.2 Elastomer

5.2.3 Polyethylene Terephthalate

5.2.4 Others

5.3 Geography

5.3.1 North America United States Canada Mexico

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East and Africa

5.3.5 South America


6.1 Company Profiles

6.1.1 B. Braun Melsungen

6.1.2 Becton, Dickinson and Company

6.1.3 Cook Medical Incorporated

6.1.4 Humacyte Inc.

6.1.5 Jotec GmbH

6.1.6 LeMaitre Vascular Inc

6.1.7 Medtronic

6.1.8 Techshot Inc

6.1.9 Terumo Medical Corporation

6.1.10 W. L. Gore and Associates


Companies Mentioned

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic
  • Techshot Inc
  • Terumo Medical Corporation
  • W. L. Gore and Associates

For more information about this report visit https://www.researchandmarkets.com/r/6ceh64


About the Author: Biotech Today

You might like

Obtaining the Campaigns list from the server has failed!
Server response:
CM Ad cahger Server plugin is not active on https://legendarygroup.co/admanager/